A Madison company that makes software approved to gauge treatment response in breast and prostate cancer patients plans to submit a second product, for blood cancers, for approval by early next year.
AIQ Solutions, which is based on technology developed at UW Carbone Cancer Center, raised $3.2 million in equity financing, the company announced this month. Capital Midwest Fund led the round, which also involved Rock River Capital Partners, 30Ventures and Wisconsin Investment Partners.